Dear National Cardiac Society President,
Dear National Cardiac Society Secretary,
Dear ESC Guidelines Coordinator,
We are now ready to set up the 2017 ESC Guidelines review teams.
In order to do so and as over the past 3 years, we are pleased to involve ALL National Cardiac Societies in the reviewing of ALL 2017 ESC Guidelines again this year.
The CPG is therefore calling upon ALL National Cardiac Societies to nominate ONE reviewer, for EACH of the below-mentioned 2017 ESC Guidelines. These nominees will need to have recognized expertise in the specific topic they will be reviewing.
- ESC Guidelines on the diagnosis and treatment of Peripheral Artery Diseases in collaboration with ESVS
- ESC / EACTS Guidelines on the management of Valvular Heart Disease
- ESC Guidelines for the management of Acute Myocardial Infarction in patients presenting with ST-segment elevation
- ESC Focused Update on Dual Anti-Platelet Therapy in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
In order to keep the manageability and a good quality of review (see attached slides) the CPG is asking the National Cardiac Societies’ reviewers to focus specifically on reviewing Grade I and III recommendations which are “the do and do not do recommendations”.
The National Cardiac Societies and their respective reviewers having been involved in the review process, as well as the ESC Committee for Practice Guidelines, will be listed in the document in an Appendix in order to acknowledge their time and effort.
Please send us the name and full contact details of your selected reviewer for each of the above-mentioned Guidelines: ONE name per Guidelines, by Monday 11 July 2016.
Nota bene: Involvement in ESC Clinical Practice Guidelines activities is subject to submission of a yearly declaration of interest which will be reviewed by an ESC assessing committee. Per the ESC policy any of the following activities will disqualify an individual from serving on a Guidelines committee: Part-time employment or salary from a related company, significant stock ownership, holding of a patent which generates significant revenues, receipt of significant royalties for intellectual property related to the topic of the guidelines.
We would like to take this opportunity to thank you for your support in the official peer reviews of the ESC Guidelines and look forward to hearing back from you.
With our best personal regards,
Professor Jose Luis Zamorano
Chairperson of the ESC Committee for Practice Guidelines 2014-2016
Professor Stephan Windecker
Chairperson of the ESC Committee for Practice Guidelines 2016-2018